e-ISSN: Pending
Negative / Null Result ReportOpen accessImmunology and Microbiology· cited by 61

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity

Henrique Lemos; Rong Ou; Caroline McCardle; Yijun Lin; J Calver; Jack Minett; Ahmed Chadli; Lei Huang · 2020 · Journal for ImmunoTherapy of Cancer

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Activating the Stimulator of Interferon Genes (STING) adaptor incites antitumor immunity against immunogenic tumors in mice, prompting clinical trials to test STING activators. However, STING signaling in the tumor microenvironment (TME) during development of Lewis lung carcinoma (LLC) suppresses antitumor immunity to promote tumor growth. We hypothesized that local immune balance favoring suppression of antitumor immunity also attenuates antitumor responses following STING activation. The purpose of this study was to evaluate how STING activation impacts antitumor responses in mic

Abstract by Henrique Lemos; Rong Ou; Caroline McCardle; Yijun Lin; J Calver; Jack Minett; Ahmed Chadli; Lei Huang, Journal for ImmunoTherapy of Cancer (2020) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1136/jitc-2020-001182